United States: Biogen Announces FDA Approval Of TOFIDENCE, A Tocilizumab Biosimilar Referencing ACTEMRA - Goodwin Procter LLP
On September 29, 2023, Biogen announced the FDA approval of TOFIDENCE (tocilizumab-bavi) intravenous formulation which is the first tocilizumab...
Full Article